26 datasets found
  1. Number of measles cases in the U.S. in 2024 and 2025, by age

    • statista.com
    Updated Apr 8, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Number of measles cases in the U.S. in 2024 and 2025, by age [Dataset]. https://www.statista.com/statistics/1560807/number-measles-cases-by-age/
    Explore at:
    Dataset updated
    Apr 8, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In 2024, there were a total of 285 cases of measles in the United States, with 120 of these cases among children aged under five years. From January 1 to April 3, 2025, there were 607 cases of measles. There were also two reported deaths from the disease during this time, the first since 2015. Measles is a highly contagious disease that can be especially dangerous for young children. Vaccines against measles resulted in a significant decrease in cases in the United States over the last few decades; however, increasing vaccine hesitancy and skepticism has been blamed for recent outbreaks.

  2. Number of measles cases reported in the U.S. from 2020-2024, by vaccination...

    • statista.com
    Updated May 29, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). Number of measles cases reported in the U.S. from 2020-2024, by vaccination status [Dataset]. https://www.statista.com/statistics/1469718/measles-cases-number-in-the-us-by-vaccination-status/
    Explore at:
    Dataset updated
    May 29, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    Jan 1, 2020 - Mar 28, 2024
    Area covered
    United States
    Description

    In 2023, there were a total of 58 cases of measles in the United States. Around 72 percent of measles cases that year were attributed to unvaccinated individuals. Meanwhile, those with two doses of vaccination only accounted for just three percent of cases. This statistic shows the number of measles cases reported in the United States from 2020 to 2024, by vaccination status.

  3. New cases of measles in the U.S. 1985-2025

    • statista.com
    • ai-chatbox.pro
    Updated Jul 8, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). New cases of measles in the U.S. 1985-2025 [Dataset]. https://www.statista.com/statistics/186678/new-cases-of-measles-in-the-us-since-1950/
    Explore at:
    Dataset updated
    Jul 8, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    There were 285 new cases of measles in the U.S. in 2024. Measles, also known as rubeola, is an infectious disease that is highly contagious and affects mostly children. Common symptoms of measles include fever, runny nose, sore throat, cough, and a rash. Although death rates from measles have decreased around the world, it is still responsible for around 81,000 deaths worldwide per year. Measles vaccination The main reason for the decrease in measles cases and deaths is due to high vaccination rates. The widely used MMR vaccine protects against measles, mumps, and rubella and is safe and effective. In 2023, around 91 percent of adolescents in the U.S. aged 13 to 17 years had received an MMR vaccination. However, in recent years there has been a rise in measles cases in many parts of the world due to vaccine hesitancy. Vaccine hesitancy Vaccine hesitancy refers to a refusal or reluctance to have children vaccinated, despite the overwhelming evidence that vaccines are safe and effective. This hesitancy comes from a misunderstanding of the ingredients in vaccines and how they work, a mistrust of doctors and pharmaceutical companies, and belief in the unfounded associations of vaccines with other diseases and disorders.

  4. Number of measles cases reported in the U.S. from 2020 to 2024, by age

    • statista.com
    Updated May 29, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). Number of measles cases reported in the U.S. from 2020 to 2024, by age [Dataset]. https://www.statista.com/statistics/1469710/number-measles-cases-in-the-us-by-age/
    Explore at:
    Dataset updated
    May 29, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    Jan 1, 2020 - Mar 28, 2024
    Area covered
    United States
    Description

    In 2023, there were around 58 measles cases in the United States, with 20 of these cases among those aged 5 to 19 years. This statistic shows the number of measles cases reported in the United States from 2020 to 2024, by age.

  5. Forecast: Number of Reported Measles Cases in the US 2024 - 2028

    • reportlinker.com
    Updated Apr 12, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    ReportLinker (2024). Forecast: Number of Reported Measles Cases in the US 2024 - 2028 [Dataset]. https://www.reportlinker.com/dataset/80ab582640adaf286b3e500c37cb96fe4b09a3fa
    Explore at:
    Dataset updated
    Apr 12, 2024
    Dataset authored and provided by
    ReportLinker
    License

    Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
    License information was derived automatically

    Area covered
    United States
    Description

    Forecast: Number of Reported Measles Cases in the US 2024 - 2028 Discover more data with ReportLinker!

  6. Number of measles cases in the U.S. in 2024, by state

    • statista.com
    Updated Mar 12, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Number of measles cases in the U.S. in 2024, by state [Dataset]. https://www.statista.com/statistics/1560812/number-measles-cases-by-state/
    Explore at:
    Dataset updated
    Mar 12, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2024
    Area covered
    United States
    Description

    In 2024, there were 285 measles cases in the United States. That year, Minnesota had the highest number of cases, followed by Illinois, and Oregon. Measles is a highly contagious disease that can be especially dangerous for young children. Vaccines against measles resulted in a significant decrease in cases in the United States over the last few decades; however, increasing vaccine hesitancy and skepticism has been blamed for recent outbreaks.

  7. Rate of new cases of measles in the U.S. 1919-2024

    • statista.com
    Updated Mar 6, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Rate of new cases of measles in the U.S. 1919-2024 [Dataset]. https://www.statista.com/statistics/186409/cases-of-measles-in-the-us-since-1950/
    Explore at:
    Dataset updated
    Mar 6, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In 1970, there were 22.79 new cases of measles per 100,000 population in the United States. However, this rate dropped to .08 in the year 2024. This statistic shows the number of new cases of measles per 100,000 population in the United States from 1919 to 2024.

  8. Forecast: Measles Incidence in the US 2024 - 2028

    • reportlinker.com
    Updated Apr 8, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    ReportLinker (2024). Forecast: Measles Incidence in the US 2024 - 2028 [Dataset]. https://www.reportlinker.com/dataset/8fd2ad59b91528056e5352273512be14a259fb84
    Explore at:
    Dataset updated
    Apr 8, 2024
    Dataset authored and provided by
    ReportLinker
    License

    Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
    License information was derived automatically

    Area covered
    United States
    Description

    Forecast: Measles Incidence in the US 2024 - 2028 Discover more data with ReportLinker!

  9. Share of measles cases in the U.S. that were hospitalized in 2024 and 2025

    • statista.com
    Updated Apr 8, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Share of measles cases in the U.S. that were hospitalized in 2024 and 2025 [Dataset]. https://www.statista.com/statistics/1560809/percentage-measles-cases-hospitalized/
    Explore at:
    Dataset updated
    Apr 8, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In 2024, there were a total of 285 cases of measles in the United States. Around 40 percent of these cases were hospitalized for isolation or for management of measles complications. From January 1 to April 3, 2025, there were 607 cases of measles, with 12 percent needing hospitalization. Measles is a highly contagious disease that can be especially dangerous for young children. Vaccines against measles resulted in a significant decrease in cases in the United States over the last few decades; however, increasing vaccine hesitancy and skepticism has been blamed for recent outbreaks.

  10. Distribution of measles cases in the U.S. in 2024 and 2025, by vaccination...

    • statista.com
    Updated Apr 8, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Distribution of measles cases in the U.S. in 2024 and 2025, by vaccination status [Dataset]. https://www.statista.com/statistics/1560808/distribution-measles-cases-by-vaccination-status/
    Explore at:
    Dataset updated
    Apr 8, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In 2024, there were a total of 285 cases of measles in the United States. Around 89 percent of these cases were among those who were unvaccinated or whose vaccination status was unknown. From January 1 to April 3, 2025, there were 607 cases of measles, with those who were unvaccinated or with an unknown vaccination status accounting for 97 percent of these cases. Measles is a highly contagious disease that can be especially dangerous for young children. Vaccines against measles resulted in a significant decrease in cases in the United States over the last few decades; however, increasing vaccine hesitancy and skepticism has been blamed for recent outbreaks.

  11. Share of measles cases in the U.S. that were hospitalized in 2024 and 2025,...

    • statista.com
    Updated Apr 8, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Share of measles cases in the U.S. that were hospitalized in 2024 and 2025, by age [Dataset]. https://www.statista.com/statistics/1560810/percentage-measles-cases-hospitalized-by-age/
    Explore at:
    Dataset updated
    Apr 8, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    United States
    Description

    In 2024, there were a total of 285 cases of measles in the United States. That year, around half of measles cases among children aged under five years were hospitalized for isolation or for management of measles complications. From January 1 to April 3, 2025, there were 607 cases of measles, with 21 percent of cases among children under five needing hospitalization. Measles is a highly contagious disease that can be especially dangerous for young children. Vaccines against measles resulted in a significant decrease in cases in the United States over the last few decades; however, increasing vaccine hesitancy and skepticism has been blamed for recent outbreaks.

  12. M

    Measles Report

    • marketresearchforecast.com
    doc, pdf, ppt
    Updated Apr 22, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Market Research Forecast (2025). Measles Report [Dataset]. https://www.marketresearchforecast.com/reports/measles-150391
    Explore at:
    pdf, ppt, docAvailable download formats
    Dataset updated
    Apr 22, 2025
    Dataset authored and provided by
    Market Research Forecast
    License

    https://www.marketresearchforecast.com/privacy-policyhttps://www.marketresearchforecast.com/privacy-policy

    Time period covered
    2025 - 2033
    Area covered
    Global
    Variables measured
    Market Size
    Description

    The global measles vaccine market is a significant sector within the broader pharmaceutical landscape, characterized by substantial growth driven by increasing vaccination campaigns and heightened awareness of the disease's potential severity. The market size in 2025 is estimated at $5 billion, reflecting a robust Compound Annual Growth Rate (CAGR) of approximately 7% from 2019 to 2024. This expansion is fueled by several key factors. Firstly, global initiatives aimed at eradicating measles, spearheaded by organizations like the World Health Organization (WHO), have significantly increased vaccination rates in many developing nations. Secondly, a rising incidence of measles outbreaks in certain regions highlights the persistent threat of the disease and necessitates sustained vaccination efforts. Thirdly, advancements in vaccine technology, leading to improved efficacy and safety profiles, contribute to increased market demand. However, challenges remain. Vaccine hesitancy and misinformation pose significant hurdles to achieving complete measles eradication. Furthermore, logistical constraints, particularly in resource-limited settings, impede effective vaccine distribution and administration. Segmentation within the market is primarily driven by application, with hospitals and clinics representing the largest consumer base. Major players like Novartis, Abbott, Johnson & Johnson, Sanofi, and Merck dominate the market, leveraging their extensive distribution networks and research capabilities. Regional analysis reveals North America and Europe as mature markets with high per capita consumption, while significant growth opportunities exist in Asia-Pacific and other developing regions. The forecast period (2025-2033) anticipates continued growth, albeit potentially at a slightly moderated CAGR, as the global vaccination rate progressively improves, but challenges related to vaccine hesitancy and equitable access remain a factor. The projected market expansion hinges on the continued success of global vaccination initiatives and the ability to overcome existing barriers to access. The market's geographical distribution reflects global health disparities. While developed regions maintain high vaccination coverage, significant investments are required in developing nations to enhance cold-chain infrastructure and public health campaigns. Furthermore, future market dynamics will be shaped by advancements in vaccine technology, potentially leading to multi-dose formulations or novel delivery systems. Competition among pharmaceutical companies will remain intense, driving innovation and pricing strategies. Long-term market success will depend on the strategic partnerships between governments, international organizations, and pharmaceutical companies to guarantee widespread and equitable access to measles vaccines.

  13. U.S. adults who thought the measles vaccine is more dangerous than measles,...

    • statista.com
    Updated Mar 11, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). U.S. adults who thought the measles vaccine is more dangerous than measles, 2024 [Dataset]. https://www.statista.com/statistics/1560956/measles-vaccine-more-dangerous-than-measles-us-adults/
    Explore at:
    Dataset updated
    Mar 11, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    Feb 20, 2024 - Feb 28, 2024
    Area covered
    United States
    Description

    A survey of adults in the United States from 2024 found that almost 20 percent thought it was definitely true or probably true that getting the measles vaccine is more dangerous than becoming infected with measles. However, this statement is false. Measles is a highly contagious disease that is especially dangerous for children. Vaccinations against measles are safe and effective and have resulted in a significant decrease in measles cases and deaths in the United States. Vaccine hesitancy and skepticism have been blamed for an increasing number of measles outbreaks lately.

  14. w

    Global Measles Attenuated Live Vaccine Market Research Report: By Vaccine...

    • wiseguyreports.com
    Updated Sep 24, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Measles Attenuated Live Vaccine Market Research Report: By Vaccine Type (Monovalent Measles Vaccine, Bivallent Measles-Rubella Vaccine, Trivalent Measles-Mumps-Rubella Vaccine), By Administration Route (Subcutaneous Injection, Intramuscular Injection), By Patient Population (Children, Adults, Pregnant Women), By Disease Severity (Mild Measles, Moderate Measles, Severe Measles), By Vaccine Formulation (Liquid, Lyophilized) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/measles-attenuated-live-vaccine-market
    Explore at:
    Dataset updated
    Sep 24, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Jan 9, 2024
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20233.16(USD Billion)
    MARKET SIZE 20243.29(USD Billion)
    MARKET SIZE 20324.5(USD Billion)
    SEGMENTS COVEREDVaccine Type ,Administration Route ,Patient Population ,Disease Severity ,Vaccine Formulation ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSRising vaccination rates Increased disease prevalence Government initiatives Technological advancements WHO initiatives
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDAstellas Pharma Inc. ,Biogen Inc. ,Eli Lilly and Company ,Johnson & Johnson Services, Inc. ,AbbVie Inc. ,Moderna ,Celgene Corporation ,GSK plc ,Pfizer Inc. ,Sanofi S.A. ,Baxter International Inc. ,Merck & Co., Inc. ,Serum Institute of India Pvt. Ltd. ,Amgen Inc.
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESIncreasing global immunization programs Rising incidence of measles outbreaks Government initiatives for vaccination drives Advancements in freezedrying technologies Growing demand for combination vaccines
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.01% (2025 - 2032)
  15. w

    Global Measles Rubella Vaccines Market Research Report: By Product (MMR...

    • wiseguyreports.com
    Updated Oct 3, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Measles Rubella Vaccines Market Research Report: By Product (MMR Vaccine, MR Vaccine, Other), By End User (Healthcare Providers, Government Agencies), By Age Group (Pediatric, Adult, Elderly), By Supply Chain (Manufacturers, Distributors, Wholesalers, Retailers), By Reimbursement (Publicly Funded Programs, Private Health Insurance) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/measles-rubella-vaccines-market
    Explore at:
    Dataset updated
    Oct 3, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Sep 24, 2025
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20231.67(USD Billion)
    MARKET SIZE 20241.75(USD Billion)
    MARKET SIZE 20322.5(USD Billion)
    SEGMENTS COVEREDDrug Class ,Route of Administration ,Disease Stage ,Chemotherapy Regimen ,Patient Population ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSRising cancer prevalence Technological advancements Development of novel therapies Increasing demand for personalized medicine Adoption of targeted therapies
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDOncovation Pharmaceuticals ,Novartis AG ,Daiichi Sankyo Company, Limited ,Axsome Therapeutics ,Sanofi SA ,Aprecia Pharmaceuticals LLC ,Protagonist Therapeutics ,Helsinn Healthcare SA ,Aprea Therapeutics ,Teva Pharmaceutical Industries Ltd. ,Zogenix, Inc. ,Strativa Pharmaceuticals ,Arsia Therapeutics ,Symphogen AG ,Eisai Co., Ltd.
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESNovel drug delivery systems Targeted therapies Improved patient care Rise in cancer incidence Personalized treatment plans
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.56% (2025 - 2032)
  16. U.S. adults who thought the vaccine is more dangerous than measles, 2024, by...

    • statista.com
    Updated Mar 11, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). U.S. adults who thought the vaccine is more dangerous than measles, 2024, by party [Dataset]. https://www.statista.com/statistics/1560957/measles-vaccine-more-dangerous-than-measles-us-by-party-id/
    Explore at:
    Dataset updated
    Mar 11, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    Feb 20, 2024 - Feb 28, 2024
    Area covered
    United States
    Description

    A survey of adults in the United States from 2024 found that 23 percent of Republicans thought it was definitely true or probably true that getting the measles vaccine is more dangerous than becoming infected with measles. However, this statement is false. Measles is a highly contagious disease that is especially dangerous for children. Vaccinations against measles are safe and effective and have resulted in a significant decrease in measles cases and deaths in the United States. Vaccine hesitancy and skepticism have been blamed for an increasing number of measles outbreaks in recent years.

  17. w

    Global Live Attenuated Vaccine Market Research Report: By Vaccine Type...

    • wiseguyreports.com
    Updated Sep 24, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Live Attenuated Vaccine Market Research Report: By Vaccine Type (Measles Vaccine, Mumps Vaccine, Rubella Vaccine, Varicella Vaccine, Yellow Fever Vaccine), By Application (Pediatric Vaccination, Travel Vaccination, Outbreak Response), By Route of Administration (Subcutaneous Injection, Intramuscular Injection, Intradermal Injection, Oral Administration), By End User (Hospitals, Clinics, Pharmacies, Government Health Agencies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/live-attenuated-vaccine-market
    Explore at:
    Dataset updated
    Sep 24, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Jan 9, 2024
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20236.5(USD Billion)
    MARKET SIZE 20246.98(USD Billion)
    MARKET SIZE 203212.3(USD Billion)
    SEGMENTS COVEREDVaccine Type ,Application ,Route of Administration ,End User ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSIncreasing burden of infectious diseases Advancements in biotechnology Growing demand for personalized vaccines Government initiatives and funding Expansion of vaccination programs
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDMerck ,Serum Institute of India ,Takeda Pharmaceutical Company ,AstraZeneca ,Novavax ,Moderna ,GlaxoSmithKline ,Bharat Biotech ,Pfizer ,Sanofi ,Abbott Laboratories ,Emergent BioSolutions ,Johnson & Johnson ,Bayer
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESIncreased Global Vaccination Demand Emerging Infectious Diseases Technological Advancements Government Initiatives and Expansion in Developing Regions
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.34% (2025 - 2032)
  18. Leading causes of death, total population, by age group

    • www150.statcan.gc.ca
    • ouvert.canada.ca
    • +1more
    Updated Feb 19, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Government of Canada, Statistics Canada (2025). Leading causes of death, total population, by age group [Dataset]. http://doi.org/10.25318/1310039401-eng
    Explore at:
    Dataset updated
    Feb 19, 2025
    Dataset provided by
    Statistics Canadahttps://statcan.gc.ca/en
    Area covered
    Canada
    Description

    Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.

  19. w

    Global Measles Mumps And Rubella Virus Vaccine Live Market Research Report:...

    • wiseguyreports.com
    Updated Jan 12, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2025). Global Measles Mumps And Rubella Virus Vaccine Live Market Research Report: By Vaccine Type (Monovalent Vaccines, Bivalent Vaccines, Trivalent Vaccines), By Packaging (Single-Dose Vials, Multi-Dose Vials, Pre-Filled Syringes), By Application (Routine Immunization, Outbreak Response, Catch-Up Immunization), By Age Group (Infants, Children, Adults), By Distribution Channel (Public Health Agencies, Private Healthcare Providers, Pharmacies, Online Retailers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/de/reports/measles-mumps-and-rubella-virus-vaccine-live-market
    Explore at:
    Dataset updated
    Jan 12, 2025
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Sep 24, 2025
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20233.1(USD Billion)
    MARKET SIZE 20243.24(USD Billion)
    MARKET SIZE 20324.6(USD Billion)
    SEGMENTS COVEREDVaccine Type ,Packaging ,Application ,Age Group ,Distribution Channel ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSRising vaccination rates Increasing government initiatives Growing awareness of disease prevention Technological advancements and Expanding healthcare infrastructure
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDGlaxoSmithKline PLC ,Merck & Co. ,Johnson & Johnson ,Serum Institute of India Pvt. Ltd ,Novavax ,SeqirusneweraModerna Therapeutics ,AstraZeneca Plc ,Sanofi Pasteur ,Bavarian Nordic ,Janssen Vaccines ,Takeda Pharmaceutical Company Limited ,BioNTech ,CSL Limited ,Pfizer Inc.
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESMMR Vaccine Shortage in Asia Pacific Africa Rising Incidence of Measles Cases Globally Government Initiatives for Vaccination Programs Increasing disposable income in developing countries Growing Awareness of Vaccine Importance
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.49% (2025 - 2032)
  20. Share of U.S. adults agreeing there's no link between measles vaccine and...

    • statista.com
    Updated Mar 11, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Share of U.S. adults agreeing there's no link between measles vaccine and autism 2024 [Dataset]. https://www.statista.com/statistics/1560959/agreement-no-link-between-measles-vaccine-and-autism/
    Explore at:
    Dataset updated
    Mar 11, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    Apr 18, 2024 - Apr 24, 2024
    Area covered
    United States
    Description

    A survey of U.S. adults from 2024 found that around 73 percent of respondents thought it was very accurate or somewhat accurate that there is no evidence of a link between measles vaccines and getting autism, as stated by the CDC. However, around a quarter of U.S. adults do not accept the CDC's statement that there is no evidence linking the measles vaccine to getting autism. Vaccinations against measles have resulted in significant decreases in cases and deaths from the disease in the United States. However, vaccine hesitancy and skepticism have been blamed for an increasing number of measles cases.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
Statista (2025). Number of measles cases in the U.S. in 2024 and 2025, by age [Dataset]. https://www.statista.com/statistics/1560807/number-measles-cases-by-age/
Organization logo

Number of measles cases in the U.S. in 2024 and 2025, by age

Explore at:
Dataset updated
Apr 8, 2025
Dataset authored and provided by
Statistahttp://statista.com/
Area covered
United States
Description

In 2024, there were a total of 285 cases of measles in the United States, with 120 of these cases among children aged under five years. From January 1 to April 3, 2025, there were 607 cases of measles. There were also two reported deaths from the disease during this time, the first since 2015. Measles is a highly contagious disease that can be especially dangerous for young children. Vaccines against measles resulted in a significant decrease in cases in the United States over the last few decades; however, increasing vaccine hesitancy and skepticism has been blamed for recent outbreaks.

Search
Clear search
Close search
Google apps
Main menu